Extracellular BAG3 is elevated in early diffuse systemic sclerosis
LETTER TO THE EDITOR|Updated:2026-03-26
|
Extracellular BAG3 is elevated in early diffuse systemic sclerosis
“In the latest research, expert xx has made significant strides in the field of xxx. By establishing the xx system, they have provided solutions to solve xx problems, opening up new directions for future research and laying a foundation for the construction of the xx system.”
Military Medical ResearchVol. 13, Issue 1, Pages: 169-172(2026)
Affiliations:
1.Biosciences Department, Durham University, Durham DH1 3LE, UK
2.Department of Medicine, Surgery and Dentistry, University of Salerno, 84081 Baronissi, Italy
3.Scleroderma Clinic, UOC Clinica Reumatologica, ASST Pini-CTO, Università Degli Studi Di Milano, Milan, Italy
Paul Freedman, Margot De Marco, Alessandra Rosati, et al. Extracellular BAG3 is elevated in early diffuse systemic sclerosis[J]. Military Medical Research, 2026, 13(1): 169-172.
DOI:
Paul Freedman, Margot De Marco, Alessandra Rosati, et al. Extracellular BAG3 is elevated in early diffuse systemic sclerosis[J]. Military Medical Research, 2026, 13(1): 169-172. DOI: 10.1186/s40779-025-00628-w.
Extracellular BAG3 is elevated in early diffuse systemic sclerosis
Effect of early administration of tetracosactide on mortality and host response in critically ill patients requiring rescue surgery: a sensitivity analysis of the STOPSHOCK phase 3 randomized controlled trial
The injury progression of T lymphocytes in a mouse model with subcutaneous injection of a high dose of sulfur mustard
The effect of cytoplasmic regions of LIF receptor on activating MAPK p42/44in HL-60 cell
Related Author
Steven O’Reilly
Giorgio Noera
Giovanni Tripepi
Colin Gerard Egan
Graziella D’Arrigo
Annalisa Pitino
Mercedes Gori
Laura Calzà
Related Institution
CE Medical Writing SRLS
National Research Council-Institute of Clinical Physiology
Institute of Clinical Physiology (IFC-CNR), Section of Rome
IRET Foundation, Ozzano Dell’ Emilia
Department of Medicine and Division of Clinical Pharmacology, School of Medicine, UNIMORE, Policlinico